Caprazene
Caprazene is an antimycobacterial compound and precursor molecule for semi-synthetic antibacterial antibiotics, used for studies on tuberculosis and Mycobacterium avium complex infections, which can be isolated from the acid-treated caprazamycin (CPZ) A-G mixture.
Para uso exclusivo en investigación. No vendemos a pacientes.
- No. CAS: 740805-17-8
- Fòrmula: C22H31N5O12
- Peso molecular:557.51
-
Almacenamiento:
Please store the product under the recommended conditions in the Certificate of Analysis.
Actividad biológica
Descripciòn
Chemical Information
-
No. CAS 740805-17-8
-
Peso molecular 557.51
-
Fòrmula C22H31N5O12
-
SMILES
NC[C@H]([C@H]([C@H]1O)O)O[C@H]1O[C@@H]([C@@]2([H])C(N(C(C(O)=O)=CCN2C)C)=O)[C@@]3([H])O[C@@H](N4C(NC(C=C4)=O)=O)[C@@H]([C@@H]3O)O
-
Structure Classification
-
Initial Source
Streptomyces sp.
-
Envío
Room temperature in continental US; may vary elsewhere.
-
Almacenamiento
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocolo
-
Research Protocol for Infectious Diseases
Infectious-disease experiments test how pathogens interact with host barriers, innate immune receptors, inflammatory signaling, pathogen replication, and tissue injury; pattern-recognition receptors such as TLRs, RIG-I-like receptors, NOD-like receptors, and inflammasomes detect microbial molecules and activate NF-κB, interferon, and cytokine responses. The central hypothesis is that infection severity reflects the balance between pathogen burden and host response: protective inflammation restricts pathogen growth, whereas excessive or mislocalized inflammation contributes to tissue damage and disease phenotype. Unresolved questions include which host pathways are protective versus pathogenic, why some infection models fail to translate to human disease, and which combined readouts best predict clinically relevant infection outcomes.
Pureza y Documentación
Referencias
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)